CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-20 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +6,250 | 84,914 | ||
| 2025-03-20 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −6,250 | 18,750 | ||
| 2025-03-17 | Prasad Raju Chief Financial Officer | Sale | −3,762 | $41.80 | $157K | 12,714 |
| 2025-03-14 | Prasad Raju Chief Financial Officer | Option exercise | +10,000 | 16,476 | ||
| 2025-03-14 | Prasad Raju Chief Financial Officer | Option exercise · Restricted Stock Units | −10,000 | 20,000 | ||
| 2025-03-14 | Prasad Raju Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +36,666 | 36,666 | ||
| 2025-03-14 | Prasad Raju Chief Financial Officer | Grant or award · Restricted Stock Units | +27,500 | 27,500 | ||
| 2025-03-14 | Patel Naimish Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +46,667 | 46,667 | ||
| 2025-03-14 | Patel Naimish Chief Medical Officer | Grant or award · Restricted Stock Units | +32,500 | 32,500 | ||
| 2025-03-14 | Kulkarni Samarth Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2025-03-14 | Kulkarni Samarth Chief Executive Officer | Grant or award · Restricted Stock Units | +82,500 | 82,500 | ||
| 2025-03-14 | Bruno Julianne Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +36,666 | 36,666 | ||
| 2025-03-14 | Bruno Julianne Chief Operating Officer | Grant or award · Restricted Stock Units | +27,500 | 27,500 | ||
| 2025-03-14 | KASINGER JAMES R. General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +36,666 | 36,666 | ||
| 2025-03-14 | KASINGER JAMES R. General Counsel and Secretary | Grant or award · Restricted Stock Units | +27,500 | 27,500 | ||
| 2025-03-12 | Kulkarni Samarth Chief Executive Officer | Sale | −4,462 | $43.32 | $193K | 185,428 |
| 2025-03-12 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,116 | $43.32 | $48K | 78,664 |
| 2025-03-12 | Bruno Julianne Chief Operating Officer | Sale | −190 | $43.32 | $8K | 8,508 |
| 2025-03-11 | Kulkarni Samarth Chief Executive Officer | Sale | −9,973 | $42.42 | $423K | 180,890 |
| 2025-03-11 | Kulkarni Samarth Chief Executive Officer | Option exercise | +9,000 | 189,890 |
Page 9 of 46 · 910 trades